| Financial Year |
March 31 2023 |
| Monetary Funds |
187,285,448.65 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,668,854.50 |
| Accounts Receivable |
141,989,959.74 |
| Advances to Suppliers |
2,384,304.86 |
| Other Receivables |
12,841,954.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
33,318,758.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
40,317,249.98 |
| Total Current Assets |
420,806,531.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,030,654,884.04 |
| Under-construction Projects |
127,408,585.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
82,810,533.28 |
| R&D expenses |
-- |
| Goodwill |
32,523,549.40 |
| Long-Term Deferred and Prepaid Expenses |
45,933,028.48 |
| Deferred Income Tax Assets |
22,979,632.44 |
| Other Non-Current Assets |
55,187,784.59 |
| Sub-Total of Non-Current Assets |
1,427,905,969.19 |
| Total Assets |
1,848,712,500.59 |
| Short-Term Loans |
77,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
89,431,773.93 |
| Accounts Received In Advance |
789.00 |
| Employee Compensation Payable |
11,689,131.69 |
| Taxes Payable |
25,601,671.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
794,434.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
120,382,989.12 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
325,400,790.13 |
| Long-term Loans |
262,925,530.88 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
89,991,616.16 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
11,565,406.45 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
427,607,456.73 |
| Total Liabilities |
753,008,246.86 |
| Paid-In Capital(Or Share Stock) |
137,249,120.00 |
| Capital Surplus |
732,029,045.79 |
| Surplus Reserve |
32,155,485.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
185,679,073.97 |
| Minority Stockholder's Interest |
8,591,514.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,087,112,738.90 |
| Owner's Equity（Stockholder's Equity） |
1,095,704,253.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,848,712,500.59 |
